Provectus Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc.

PVCT 0.0700

+0.3%

Nov 21 3:07 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: NTTG who wrote (11764)	2/15/2013 5:49:08 PM
From: Mimbari	2 Recommendations Read Replies (2) of 13111

He is referring to the bystander effect I think. The treated lesion was fixed, but something made it to the lung. Considering that the immune system may take a bit to get going for the bystander effect, there is not enough data to make that assumption that it really failed. Did the met go away after the end of the observation period? Did they go after the met before the bystander effect kicked in? What was the time between the treated lesion and the time where the met was observed. Not enough data to make any assumptions.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next